Review of medical records for children with Central Precocious Puberty in China
Official title: Patient Characteristics, Treatment Patterns, and Resource Usage in Children Diagnosed With Central Precocious Puberty (CPP) in China
Run by Takeda · NCT05341128 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study looks at the medical records of around 1000 children in China with Central Precocious Puberty to see how they were treated and what resources were used over the past two years.
Quick facts
| Study type | Observational |
|---|---|
| Ages | Any age to 18 Years |
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | Takeda Industry-sponsored |
| Locations | 5 sites (Nanning, Guangxi and 4 other locations) |
| Trial ID | NCT05341128 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are pediatric patients diagnosed with CPP who have been treated with GnRHa and have available medical records from the specified centers.
✕Probably not a fit
Patients who have not received GnRHa treatment or lack sufficient data for analysis will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to analyze medical records of approximately 1000 children diagnosed with Central Precocious Puberty (CPP) in China. It focuses on evaluating treatment patterns, participant characteristics, and resource usage over a period of 24 months or less. The study utilizes data from the Chinese CPP Big Data Platform database and will be conducted across multiple centers in China over approximately three years. No new treatments will be administered, as the study is retrospective and non-interventional.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the treatment effectiveness and resource utilization for children with CPP, potentially guiding future treatment strategies.
How similar studies have gone: While this study is observational and retrospective, similar studies have successfully utilized medical record analysis to inform treatment practices in pediatric populations.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: • Participants diagnosed with CPP and treated with GnRHa from the centers participating in this study within the Chinese CPP Big Data Platform database since 2015 to 2024. CPP diagnosis is based on the clinical assessment and description by CPP specialized doctors. Exclusion Criteria: * Not received GnRHa as the treatment for CPP. * No available data for analysis.
Where it's running
-
The Second Affiliated Hospital of Guangxi Medical University
Nanning, Guangxi, China Recruiting -
Hainan Women and Children's Medical Center
Haikou, Hainan, China Recruiting -
Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology
Wuhan, Hubei, China Recruiting -
Shandong Provincial Hospital Affiliated to Shandong First Medical University
Jinan, Shandong, China Recruiting -
Tianjin Medical University General Hospital
Tianjin, Tianjin, China Recruiting
Study contacts
- Study coordinator: Takeda Contact
- Email: medinfoUS@takeda.com
- Phone: +1-877-825-3327
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Leuprorelin 1-Month in Children with Central Precocious Puberty
This study tests whether a 1-month formulation of leuprorelin can safely manage central precocious puberty in children over 24 months.
-
Basal LH threshold for diagnosing central precocious puberty
This study tests whether a single, baseline LH measurement can correctly diagnose central precocious puberty in kids and reduce the need for the LHRH stimulation test.
-
INSL3 as a Biomarker to See If Puberty Has Started
Researchers are testing whether a single blood test for INSL3 can tell if a child’s puberty has begun, potentially reducing need for the GnRH stimulation test.
-
Evaluation of Central Precocious Puberty and Related Neurodevelopmental Conditions
This study looks at how often kids are diagnosed with Central Precocious Puberty and whether it’s linked to other developmental conditions.
-
Combining traditional Chinese medicine and acupuncture for treating early puberty in girls
This study is testing whether a combination of traditional Chinese medicine and acupuncture can help girls with early puberty feel better and manage their symptoms.
-
Observing how the environment affects reproductive health
This study looks at how different environmental factors might affect reproductive health in people aged 8 and older, including issues like infertility and hormone problems.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.